🇺🇸 FDA
Patent

US 6946441

Inhibition of histone deacetylase as a treatment for cardiac hypertrophy

expired A61KA61K31/165A61K31/19

Quick answer

US patent 6946441 (Inhibition of histone deacetylase as a treatment for cardiac hypertrophy) held by The Board of Regents of the University of Texas System expires Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 20 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/165, A61K31/19, A61K31/401, A61K38/12